3 ms·
It seems the prinicpal "R&D incentive" that the parent poster considered was IP/patent law. Im not sure how that baby could be split in an A/B test. Pharma com
by s1artibartfast 3y ago
It seems the prinicpal "R&D incentive" that the parent poster considered was IP/patent law. Im not sure how that baby could be split in an A/B test.
Pharma companies receive very little (relatively) in terms of grants or research funding.
R&D spending can be amortized as a business expense when calculating a tax bill, so I suppose that could be repealed, raising the effective tax rate.
- sudosysgen 3y agoPharma companies receive easy and extremely subsidized access to research that costs almost a hundred billion every year. They don't need to be the direct recipients of the grant to be the direct benefactors.